Concepedia

Soo S. Ko

SS

Statistics

Publications

35

Citations

1.9K

H-Index

24

Active since

1980

Affiliations

Bristol-Myers Squibb (United States)(Current)

Wilmington University

DuPont (United States)

Experimental Station

Bristol-Myers Squibb (Germany)

Soo S. Ko is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and medicine.

Top concepts

Publications per year

1980–2019

35

Publications

35

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Journal of Medicinal Chemistry · 2000 · 299 citations · Full text

Stereocontrolled synthesis of D-pentitols, 2-amino-2-deoxy-D-pentitols and 2-deoxy-D-pentitols from D-glyceraldehyde acetonide

N. MINAMI, Soo S. Ko, Yoshito Kishi · Journal of the American Chemical Society · 1982 · 224 citations

, , +13

The increase in intracellular free calcium associated with IgG gamma 2b/gamma 1 Fc receptor-ligand interactions: role in phagocytosis.

John Ding‐E Young, Soo S. Ko, Z A Cohn · Proceedings of the National Academy of Sciences · 1984 · 155 citations · Full text

, , +19

Lanosterol 14 alpha-methyl demethylase. Isolation and characterization of the third metabolically generated oxidative demethylation intermediate.

Robert T. Fischer, J M Trzaskos, Ronald L. Magolda et al. · Journal of Biological Chemistry · 1991 · 119 citations · Full text

Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Antimicrobial Agents and Chemotherapy · 1999 · 119 citations · Full text

, , +15

1–5 of 35